Neurotech’s Encelto is surgically implanted and delivers genetically modified cell therapy to the eye Neurotech Pharmaceuticals Inc.’s research efforts are paying off. The biotech company, focused on ...
Neurotech International has received Human Research Ethics Committee approval to start a phase III clinical study, evaluating NTI164 in autism spectrum disorder Levels 2 and 3. The HREC approval ...
Neurotech International has received Human Research Ethics Committee approval to start a phase III clinical study, evaluating NTI164 in autism ... Read More The post Neurotech gets crucial ethics ...
The HREC approval represents a critical regulatory and strategic milestone for Neurotech International (ASX:NTI) enabling the initiation of clinical activities for the pivotal trial, including site ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results